How a Single Viral Protein Hijacks Immune Cells to Supercharge COVID-19 Infection
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy…
Gladstone Press Room
Find the latest news, high-quality multimedia, and expert contacts to ensure accurate and impactful storytelling. Our media team is here to assist you.
Media Contacts
Kelly Quigley
Director of Science Communications & Media Relations
kelly.quigley@gladstone.ucsf.edu
Julie Langelier
Director, Strategic Communications and Creative Operations
julie.langelier@gladstone.ucsf.edu
Sign Up to Receive Press Releases
Be the first to know about new scientific findings and other announcements from Gladstone.
Latest News
Read
Read
Rethinking ‘Exhausted’ T Cells: Gilbert Herrera Named Inaugural Ellen & Bernard Marson Fellow
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
Read
The 2026 Ogawa-Yamanaka Stem Cell Prize Awarded to Jun Takahashi
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
Read
Scientists Decode Gene Circuits of Human Immunity, Fueling New Era of Disease Research
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Read
Ask a Scientist: Can We Turn Off the Molecular Switches That Cause Heart Failure?
Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of…
Read
New Toolkit Turns Macrophages Into Better Cancer Fighters
Gladstone and UCSF scientists developed a method to genetically edit myeloid cells, immune cells that act as the body’s first…
Connect With an Expert
Gladstone’s investigators are at the forefront of biomedical research, covering a wide range of critical and emerging fields.
Trending Topics
- H5N1 Bird Flu
- Measles Outbreaks
- AI for Drug Discovery
- Drug Resistant Infections
- Advances in Alzheimer’s Research
- Stem Cells to Repair the Heart
All Areas of Expertise
- Alzheimer’s and Other Dementias
- Antibiotic Resistance
- Artificial Intelligence for Drug Discovery
- Autoimmune Diseases
- Cancer
- COVID-19 and Long COVID
- CRISPR Genome Editing
- Heart Disease
- HIV/AIDS
- Multiple Sclerosis
- Stem Cells and Regenerative Medicine
- Traumatic Brain Injury
- Vaccines
- Viruses and Infectious Diseases
Our Experts
Deepak Srivastava, MD
Gladstone President
Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease, and director of the Roddenberry Stem Cell Center.
Talk to Deepak about:
- Stem cells for curative therapies
- Artificial intelligence for drug discovery and development
- Latest discoveries for heart health
Benoit Bruneau, PhD
Senior Investigator and Director, Gladstone Institute of Cardiovascular Disease
Steve Finkbeiner, MD, PhD
Senior Investigator and Director, Gladstone Center for Systems and Therapeutics
Alex Marson, MD, PhD
Senior Investigator and Director, Gladstone-UCSF Institute of Genomic Immunology
Lennart Mucke, MD
Senior Investigator and Director, Gladstone Institute of Neurological Disease
Melanie Ott, MD, PhD
Senior Investigator and Director, Gladstone Infectious Disease Institute
Katie Pollard, PhD
Senior Investigator and Director, Gladstone Institute of Data Science and Biotechnology
Latest News
Read
Scientists Map the Interactions of Key Proteins Linked with Profound Autism
Gladstone Investigator Nevan Krogan discusses how researchers are connecting hundreds of autism-linked genes to the proteins they affect, helping identify common biological pathways that could lead to new treatments.
Read
The Molecular Map of Autism: A Road to Potential Drug Targets
A group of scientists, led by Gladstone Investigator Nevan Krogan, studied 100 autism risk genes and found that many patient-derived mutations disrupt core biological processes—a discovery that opens new avenues for future interventions.
Read
Shinya Yamanaka Made Cells Young Again. Can That Reverse Aging?
Gladstone Investigator Shinya Yamanaka reflects on the past 20 years since his groundbreaking discovery of iPS cells and its potential to transform human health.
Read
PICI Invests More Than $1 Million in Five Early Career Researchers Advancing the Future of Cancer Immunotherapy
Five investigators, including Jingya Qiu, will receive more than $1 million in combined funding to advance research projects that will accelerate the development of next-generation immunotherapies for cancer patients.
Facts and Figures
Research Labs
Years of disease-driven research
Scientists
Institutes
Gladstone Institutes is an independent, nonprofit research organization driving a new era in biomedical innovation—an era in which it’s possible to contemplate cures, not just treatments.
Media Assets
For specific assets not provided here, submit a request with our media relations team.
Featured Videos
Read
Science in Seconds | An Unprecedented Map of Human Immune Cells
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for…
Read
This Is AI Designing Its Own Experiments
Gladstone scientists have developed a thinking microscope powered by artificial intelligence.
Read
This Is AI Predicting New Ways to Treat Disease
How do brain cells change with age? How are liver cells impacted when someone takes a new medicine? What happens…
Read
This Is AI Decoding the Genetic Cause of Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in…
Read
Science in Seconds | A New Path Toward Life Without Daily HIV Pills
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the…
Read
Science in Seconds | Researchers Discover New Bacterial Immune Systems
Seth Shipman and his team recently identified seven new retrons from environmental bacteria by sampling soil and water in nature.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now